Abstract
Background Arabic-speaking refugees are the largest group of resettled persons in the United States since 2008, yet little is known about their rates of healthcare access, utilization and satisfaction.
Methods From January to December 2019, a household survey was conducted of Arabic-speaking refugees resettled in CT. Data collected included demographics, prevalence of chronic conditions, patterns of health seeking behavior, insurance status and patient satisfaction using the Patient Satisfaction Questionnaire (PSQ-18).
Results Sixty-five households responded to the survey representing 295 Arabic-speaking refugees – of which 141 (48%) were children. Forty-seven households (72%) reported members with chronic conditions, 62 persons (21%) needed daily medication, 285 (97%) persons were insured. Respondents reported high median patient satisfaction with wide variation.
Conclusion Arabic-speaking refugees resettled in CT are young but have similar adult rates of chronic medical conditions as the host community. They majority remained insured after RMA lapsed. They expressed median high satisfaction with health services but with wide variation. Inaccessibility of health services in Arabic and difficulty obtaining medications remain areas in need of improvement.
- Refugee health
- access to health services
- patient satisfaction
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study received support from an intramural award from the Yale MacMillan Center Program on Refugees, Forced Displacement, and Humanitarian Responses Faculty Grant
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Yale University IRB
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data available upon request of the authors
